TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 74 filers reported holding TRICIDA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,897 | -99.8% | 32,029 | -86.1% | 0.00% | – |
| Q3 2022 | $2,419,000 | +40.0% | 230,852 | +29.3% | 0.00% | – |
| Q2 2022 | $1,728,000 | +86300.0% | 178,502 | +96387.6% | 0.00% | – |
| Q1 2022 | $2,000 | -100.0% | 185 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $16,959,000 | -42.6% | 549,365 | -26.7% | 0.00% | -33.3% |
| Q2 2019 | $29,566,000 | -36.9% | 749,265 | -38.2% | 0.00% | -50.0% |
| Q1 2019 | $46,849,000 | +79.7% | 1,213,065 | +9.7% | 0.01% | +50.0% |
| Q4 2018 | $26,069,000 | -22.8% | 1,105,565 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $33,775,000 | +1.3% | 1,105,565 | -0.8% | 0.00% | 0.0% |
| Q2 2018 | $33,329,000 | – | 1,114,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |